Sarcolemmal Na + /H + exchanger 1 (NHE1) activity is essential for the intracellular pH (pH i ) homeostasis in cardiac myocytes. Emerging evidence indicates that sarcolemmal NHE1 dysfunction was closely related to cardiomyocyte death, but it remains unclear whether defective trafficking of NHE1 plays a role in the vital cellular signalling processes. Dynamin (DNM), a large guanosine triphosphatase (GTPase), is best known for its roles in membrane trafficking events. Herein, using co-immunoprecipitation, cell surface biotinylation and confocal microscopy techniques, we investigated the potential regulation on cardiac NHE1 activity by DNM. We identified that DNM2, a cardiac isoform of DNM, directly binds to NHE1. Overexpression of a wild-type DNM2 or a dominant-negative DNM2 mutant with defective GTPase activity in adult rat ventricular myocytes (ARVMs) facilitated or retarded the internalization of sarcolemmal NHE1, whereby reducing or increasing its activity respectively. Importantly, the increased NHE1 activity associated with DNM2 deficiency led to ARVMs apoptosis, as demonstrated by cell viability, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling assay, Bcl-1/Bax expression and caspase-3 activity, which were effectively rescued by pharmacological inhibition of NHE1 with zoniporide. Thus, our results demonstrate that disruption of the DNM2-dependent retrograde trafficking of NHE1 contributes to cardiomyocyte apoptosis.
Introduction
Na + /H + exchangers (NHEs), a ubiquitously expressed family of integral membrane proteins, play important roles in the regulation of intracellular pH (pH i ) via H + extrusion driven by transmembrane Na + gradient [1] . To date, 12 mammalian isoforms of NHE have been identified, although NHE1 is the primary acid extrusion system in cardiac cells [2] . Several studies have demonstrated that sarcolemmal NHE1 dysfunction was closely related to cardiomyocyte death under pathophysiological conditions such as ischaemia-reperfusion injury, ventricular hypertrophy and myocardial infarction, underlying the pathophysiological importance of the fine-tuned NHE1 activity [3] [4] [5] [6] .
NHE1 activity is dynamically changed in response to the fluctuation of pH i , and is also subject to the modulation by various extracellular stimuli, such as growth factors, hormones, integrin engagement [7] [8] [9] , and the intracellular messengers such as protein kinase A, mitogen-activated protein kinase and Ca 2+ /calmodulin complex [10] [11] [12] . The enhancement of NHE1 activity in parallel with the increase in its membrane expression implicated the involvement of a protein trafficking process in the regulation of NHE1 activity [13] . However, the molecular mechanism underlying this process remains undefined.
Dynamin (DNM) is a superfamily of large guanosine triphosphatases (GTPase) that hydrolyse GTP to form GDP [14] . Mammals express three DNM isoforms, of which DNM2 is ubiquitously expressed; DNM1 and DNM3 are predominantly distributed in neurons and testis respectively [15] . DNM is best known for its roles in membrane-trafficking processes, for example, caveolae-mediated and clathrin-dependent endocytosis, trafficking from the trans-Golgi network and membrane invagination/fission [16] [17] [18] [19] . A recent study reported the regulatory effects of DNM on sarcolemmal L-type calcium channel [20] , suggesting the potential role of DNM in the cardiomyocyte membrane-related protein trafficking. In this study, we aimed to determine whether cardiac DNM can modulate the trafficking and activity of sarcolemmal NHE1, and if so, to explore the related physiological implication.
Materials and methods

Construction of adenoviral vectors
The wild-type (WT) and the mutated form (K44A, defective in GTP binding) of DNM2 were used in the manipulation of DNM2 activity. Briefly, the cDNAs of rat DNM2 K44A sequences were subsequently recombined with the pAd/CMV/V5-DEST vector using LR Clonase â enzyme mix (Invitrogen) to yield the pAd/CMV/V5-DEST-DNM2-WT or pAd/CMV/V5-DEST-DNM2-K44A construct. The recombinant adenoviruses harbouring the DNM2 WT /DNM2 K44A gene were generated in HEK293 cells and titrated as described previously [21] .
Isolation of ventricular myocytes and adenoviral gene transfer
The protocol for animal experiments was approved by the Institutional Animal Care and Use Committee of Tongji University. Adult rat ventricular myocytes (ARVMs) were isolated from male Sprague-Dawley rats weighing 250-300 g, plated on laminin-coated dishes and cultured according to a protocol described previously [22] . Adenovirus-mediated gene transfer was performed by adding the vectors encoding DNM2 WT or DNM2 K44A into culture medium at the desired multiplication of infection (MOI). GFP-or b-gal-expressing viruses were used as a mock control. In some sets of the experiments, the infected cells were treated with zoniporide (Tocris, Minneapolis, MN, USA) at 1 lM for 36 hrs. The viability of the infected ARVMs was evaluated by Trypan Blue exclusion, as described elsewhere [23] .
Cell-surface biotinylation
The ARVMs were washed with cold PBS and incubated with 2 mg/ml sulfo-NHS-LC-Biotin (Pierce, Rockford, IL, USA) for 30 min. at 4°C. Unreacted biotin was quenched by a Quenching solution containing 100 mM glycine in PBS. The cells were subsequently lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1% sodium deoxycholate, 1% NP-40, 1 mM PMSF and 1 mM EDTA). The lysates containing biotinylated proteins were incubated with pre-washed streptavidin-agarose beads (Pierce) at 4°C overnight. After three washes, bound surface proteins were eluted and separated by SDS-PAGE.
Co-immunoprecipitation and western blotting
The protein extracts from freshly isolated ARVMs were pre-cleaned by Protein G Sepharose (Sigma-Aldrich, St. Louis, MO, USA) and then incubated with 5 lg of primary antibodies for 2 hrs, followed by Protein G Sepharose for 1 hr. The Sepharose were washed five times and boiled in Laemmli buffer for analyses of the associated proteins by SDS-PAGE. Western blotting was performed with the primary antibodies against DNM2 (Abcam, Cambridge, MA, USA), NHE1 (Santa Cruz, Dallas, TX, USA), Bcl-2 (Beyotime, Jiangsu, China), Bax (Cell signaling, Boston, MA, USA), cleaved caspase-3 (Cell signaling, Boston, MA, USA) and GAPDH (Cell signaling, Boston, MA, USA).
NHE1 trafficking experiments in HEK293 cells
NHE1 trafficking was studied in HEK293 cells, as reported previously [24] . The plasmid encoding human NHE1 and GFP (hNHE1-GFP) fusion protein was a gift from Dr. Chi-Hung Lin (National Yang-Ming University, Taiwan). One day before transfection, the cells were plated on coverslips in 35-mm dishes at 40-50% confluence. Transfection was performed with 1.6 lg of hNHE1-GFP plasmid and Lipofectamine 2000 TM transfection reagent (Invitrogen) according to the manufacturer's instructions. After 24 hrs, Adv-DNM2 WT , -DNM2 K44A or a mock vector was added for another 24 hrs prior to imaging analyses.
Measurement of Na
+ /H + exchanger activity
The activity of NHE1 was measured as the rate of Na + -dependent pH i recovery following an acid load (NH 4 Cl pre-pulse) as described previously [25] . Briefly, cultured ARVMs were loaded with the membrane-permeable form of a pH i indicator 2′, 7′-bis (carboxyethyl)-5 (6)-carboxyfluorescein ester (BCECF-AM) (1 lM, Dojindo Laboratories, Rockville, MD, USA) for 30 min. at 37°C. The cells were then rinsed with HEPES-buffered Tyrode's solution (in mM: NaCl 140, KCl 5, Hepes 10, CaCl 2 2, MgCl 2 1; pH 7.4 with NaOH). After the baseline pH i was recorded, the cells were perfused with an acid-loaded solution based on the Tyrode's composition with the following substitutions: NaCl and KCl were, respectively, replaced with 20 mM NH 4 Cl and 120 mM N-methyl-D-glucamine (NMDG/Cl). Subsequently, normal Tyrode's solution was added to yield the NHE activity as the pH i recovery rate. Throughout the experiment, the pH i was monitored using a Leica SP5 inverted microscope. The cells were excited successively at 490 and 450 nm. The 490/450 emission ratio obtained from the intracellular BCECF-AM was converted to a linear pH scale using in situ data calibration, which was performed at the end of each experiment using the nigericin technique described elsewhere [26] . 
Measurement of caspase-3 activity
Caspase-3 activity was measured using a colorimetric assay kit (Beyotime) according to the manufacturer's instructions.
Statistical analysis
Data are presented as means AE SEM. Statistical significance was determined by a one-way ANOVA or unpaired Student's t-test where appropriate. A value of P < 0.05 was considered to be statistically significant.
Results
Sarcolemmal NHE1 trafficking is dependent on the DNM2 GTPase activity in the cardiomyocyte DNM2 is a ubiquitous DNM other than the neuron-specific DNM1 and DNM3 [15] , and our previous study identified DNM2 as the single isoform of DNMs in the rat heart (J Li, L Xu, JC Ye, X Li, DS Zhang, DD Liang, XR Xu, M Qi, CM Li, H Zhang, J Wang, Y Liu, YH Chen, unpublished data). To determine whether the GTPase activity of DNM2 affects sarcolemmal NHE1 trafficking, we specifically enhanced or inhibited the DNM2 activity by overexpressing a WT DNM2 (DNM2 WT ) or a dominant-negative DNM2 mutant (DNM2 K44A , defective for GTPase activity) in the cardiomyocytes respectively. The transfection efficiency was evaluated by fluorescent microscopy and western blotting at 24 hrs after infection. As shown in Figure 1A , the expression level of DNM2 was markedly up-regulated (three-to fourfold) by the overexpression of DNM2
WT or DNM2
K44A
. The expression of membrane-bound NHE1 was analysed by cell-surface biotinylation to detect the retrograde trafficking of NHE1 from the sarcolemma to the cytosol. Compared with the mock control, DNM2
WT overexpres- sion reduced the surface NHE1 level, suggesting an enhanced internalization of sarcolemmal NHE1; whereas overexpression of DNM2 K44A led to an increase in NHE1 expression in the surface, indicating an impaired retrograde trafficking of NHE1 (Fig. 1B) . We then investigated whether DNM2 regulated the NHE1 trafficking via a direct interaction. The protein extracts from freshly isolated ARVMs were immunoprecipitated with a specific antibody against NHE1 or DNM2. Immunoprecipitation with the anti-NHE1 antibody revealed the complex formation between NHE1 and DNM2. Similar results were obtained from the reciprocal experiments (Fig. 1C) .
The DNM2-dependent regulation of NHE1 trafficking was further tested in HEK293 cells. In the absence of exogenous DNM2
WT or DNM2 K44A , NHE1 was mostly located on the cell surface with only a small fraction in the cytoplasm. Overexpression of DNM2 WT ( Fig. 2A ) caused a significant translocation of membrane NHE1 into the cytoplasm. In contrast, DNM2
K44A overexpression detained NHE1 protein on the cell surface (Fig. 2B ).
DNM2-dependent NHE1 trafficking is coupled with the change in NHE1 activity
To determine whether the alteration in the DNM2-dependent NHE1 translocation modified NHE1 activity, we assayed the activity of NHE1 in the ARVMs overexpressing DNM2
K44A
. The response of these cells to an acute acid load induced by the application of NH 4 Cl in the extracellular solution was assessed. As shown in Figure 3A through C, when NH 4 Cl was removed and the Na + -Tyrode's solution was reintroduced, the pH i began to recover because of the NHE1-mediated H + extrusion. The rate of this Na + -dependent intracellular alkalinization, which was calculated from the point at which the pH i started to recover and is indicated by the dotted line in each trace, represents the NHE1 activity. The Na + -dependent pH i recovery was slower in the ARVMs overexpressing DNM2
WT than in the ARVMs receiving the mock vector (0.041 AE 0.001, n = 57 cells versus 0.068 AE 0.002 pH i units/min., n = 50 cells), whereas a markedly accelerated pH i recovery was observed in the ARVMs overexpressing DNM2 K44A (0.142 AE 0.001 pH i units/min., n = 60 cells; Fig. 3D ). In addition, compared with mock control or DNM2 WT overexpression, DNM2 K44A overexpression resulted in an elevated resting pH i (Fig. 3E) .
Increased NHE1 activity induced by impaired retrograde trafficking contributes to apoptotic death in DNM2-defective ARVMs
We next explored the potential effect of the DNM2 deficiency-induced NHE1 activation on the viability of ARVMs. As shown in Figure 4 , the viability of the DNM2 K44A -ARVMs (45.2 AE 1.3%, n = 5) was markedly lower than that in mock control (92.5 AE 1.6%, n = 5) or the DNM2 WT -ARVMs (91.8 AE 1.4%, n = 5). The treatment with zoniporide, a selective NHE1 inhibitor [27] , improved the viability of DNM2 K44A -ARVMs (61.6 AE 1.8%, n = 5), and had no effect on the -ARVMs (12.5 AE 0.8%, n = 5; Fig. 5A and B) . These results implicated that sarcolemmal NHE1 activation induced by the defective DNM2-dependent trafficking contributes to the apoptotic death of ARVMs.
The DNM2-and NHE1-associated apoptosis in ARVMs was further substantiated by the finding that the DNM2 K44A overexpression reduced the level of Bcl-2 protein, which functions at the contact sites of the mitochondrial membrane to inhibit apoptosis [28] . Moreover, the level of pro-apoptotic Bax was increased by the overexpression of DNM2 K44A . When zoniporide was applied, the alteration in Bcl-2 or Bax level was significantly alleviated (Fig. 5C-E) .
Caspase-3 activation is the terminal step in the apoptotic pathway [29] . Using western blotting and caspase activity measurements, we detected the endogenous levels of the large fragment of activated caspase-3 and the caspase-3 protease activity. As shown in Figure 5C , F and G, overexpression of DNM2 K44A but not DNM2 WT induced an increase in caspase-3 activity, which was partially inhibited by zoniporide.
Discussion
In this study, we demonstrate for the first time that in ARVMs, sarcolemmal NHE1 activity is regulated by a DNM2-dependent trafficking process. DNM2 up-regulation decreased the NHE1-mediated H + extrusion, whereas its deficiency led to an augment in the NHE1 activity. Interestingly, NHE1 activation elicited by DNM2 deficiency induced cardiomyocyte apoptosis, which can be partially rescued by pharmacological inhibition of NHE1 activity.
NHE1 has been primarily considered to be a membrane 'housekeeping' resident protein, yet the regulation of sarcolemmal NHE1 translocation in cardiomyocytes has not been explored. Recent studies indicate that membrane NHE1 has a half-life of~24 hrs [30] and that increased metabolic activity or ischemia can modify the translocation of NHE1 [31] , which suggests the existence of dynamic trafficking of membrane NHE1. In this study, we have investigated whether a net translocation of NHE1 to the sarcolemma of cardiomyocytes was regulated by DNM2, a key player in intracellular internalization, and we confirmed the occurrence of this process through cellsurface biotinylation and complementary techniques of immunofluorescence microscopy. Our results indicate that the membrane expression of NHE1 was changed in response to the alteration of DNM2 activity (Fig. 1B) , and this finding was corroborated in HEK293 cells overexpressing exogenous NHE1 (Fig. 2) . Moreover, co-immunoprecipitation revealed a tight association between NHE1 and DNM2 in ARVMs (Fig. 1C) . Taken together, these data suggest that the trafficking of sarcolemmal NHE1 between cell surface and cytoplasm can be regulated by DNM2 activity.
Internalization of plasmalemmal transporters is not only involved in their catabolism but also in the regulation of the number of the membrane-bound transporters, thereby affecting their activity [32] . The activation of intrinsic catalytic activity of NHE1 has been extensively studied and established experimentally [33] . We hereby report a DNM2-mediated endocytic regulation of sarcolemmal NHE1 activity in cardiomyocytes. The confocal microscopy of the ARVMs loaded with BCECF-AM showed that the NHE1 activity was decreased in the DNM2
WT -overexpressing cells, although it was raised by the overexpression of DNM2
K44A
, accompanied by the upregulation of resting pH i (Fig. 3) . The increase in the surface amount of NHE1 as a result impaired endocytosis may contribute to the activation of NHE1 and lead to enhanced H + extrusion, resulting in the intracellular alkalinization. In contrast, the reduction in surface NHE1 expression caused by excessive internalization decreased the activity of NHE1. The relatively small change in the NHE1 activity and the lack of a significant drop of the resting pH i in the DNM2 WT -overexpressing cells was probably attributed to the minimal activity of sarcolemmal NHE1 under basal condition [3] and/or the involvement of mitochondrial NHE activity [34] .
The activation of NHE1 has been convincingly demonstrated to regulate cardiomyocyte apoptosis and to be deleterious in a number of pathophysiological conditions, including left ventricular hypertrophy, congestive heart failure and myocardial infarction [35, 36] . This study demonstrates that the deficiency of DNM2 leads to a decreased cell viability and promotes apoptotic cell death, which is partially reversed by the inhibition of NHE1 activity (Figs 4, 5A and B) , suggesting an important role for NHE1 activation in the regulation of cardiomyocyte apoptosis. Several lines of evidence support the deleterious effects of the enhanced NHE1 activation in the DNM2 deficiency-mediated cardiomyocyte death. On one hand, excessive Na + influx through the activated NHE1 may activate the sarcolemmal Na + /Ca 2+ exchanger, leading to the augmentation of Ca 2+ influx into the cytosol and the ensuing cell death [37, 38] . On the other hand, the intracellular alkalinization by the overactivation of NHE1 may be an early event in the apoptotic cascade [39] , occurring prior to caspase activation and DNA fragmentation. Moreover, a reduced expression of DNM2 and an activation of NHE1 were also found in ischaemic myocardium of rat (data not shown), further underscoring the potential pathological importance of DNM2 deficiency-mediated NHE1 activation in the heart. Caspase-3 represents the common pathway of the caspase cascade and has been implicated in the apoptosis of cardiomyocytes [40] . The results that the caspase-3 activity was elevated by the overexpression of DNM2 K44A (Fig. 5C , F and G) confirmed the DNM2 deficiency-mediated apoptosis. Bax contributes to the progression of apoptosis by disrupting the function of mitochondrial membranes, whereas Bcl-2 binds to and inactivates Bax to prevent apoptosis [41] . A robust increase in Bax expression and a reduction in Bcl-2 level were observed in the DNM2-defective ARVMs (Fig. 5C-E the activation of the mitochondrial-dependent apoptosis pathway. The use of zoniporide partially alleviated the alteration in the expression levels of Bcl-2, Bax and cleaved caspase-3, underlying the involvement of NHE1 activation. The lack of full rescue from apoptosis by zoniporide suggests that there may be targets other than NHE1 that can be regulated by DNM2 and also contribute to the maintenance of cell survival. These issues remains to be addressed in future studies.
In summary, this study demonstrates that the activity of sarcolemmal NHE1 can be regulated by a DNM2-dependent trafficking. The enhanced activation of NHE1 induced by DNM2 deficiency leads to cardiomyocyte apoptosis. These findings provide a novel mechanism by which the aberrant NHE1 trafficking affects cardiomyocyte survival and may offer new insights regarding the pathogenesis and management of myocardial injury.
